rs56248469
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_000875.5(IGF1R):c.1784G>A(p.Arg595His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,614,140 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000875.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF1R | NM_000875.5 | c.1784G>A | p.Arg595His | missense_variant | 8/21 | ENST00000650285.1 | NP_000866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF1R | ENST00000650285.1 | c.1784G>A | p.Arg595His | missense_variant | 8/21 | NM_000875.5 | ENSP00000497069.1 | |||
IGF1R | ENST00000559925.5 | n.1784G>A | non_coding_transcript_exon_variant | 8/10 | 1 | |||||
IGF1R | ENST00000649865.1 | c.1784G>A | p.Arg595His | missense_variant | 8/21 | ENSP00000496919.1 | ||||
IGF1R | ENST00000560144.1 | n.62G>A | non_coding_transcript_exon_variant | 1/4 | 3 | ENSP00000456950.1 |
Frequencies
GnomAD3 genomes AF: 0.000670 AC: 102AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000644 AC: 162AN: 251468Hom.: 0 AF XY: 0.000633 AC XY: 86AN XY: 135912
GnomAD4 exome AF: 0.00154 AC: 2253AN: 1461852Hom.: 6 Cov.: 34 AF XY: 0.00149 AC XY: 1086AN XY: 727232
GnomAD4 genome AF: 0.000670 AC: 102AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74464
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 17, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 26, 2023 | Reported in the heterozygous state in a patient with isolated craniosynostosis (PMID: 21204214); Functional studies conducted on a cell line derived from the previously published patient harboring this variant, showed increased IRS1 and GSK3 phosphorylation; however additional studies are needed to validate the functional effect of this specific variant (PMID: 23073384); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23073384, 21204214) - |
Growth delay due to insulin-like growth factor I resistance Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at